. Cancer mortality and saccharin consumption in diabetics. The mortality experience of 5971 members of the British Diabetic Association (BDA) was followed-up for between five and eight years to mid-1973. Overall, 1207 deaths occurred compared with 778 expected from the mortality of the population of England and Wales in 1972. This excess of deaths was due almost entirely to diabetes mellitus and ischaemic heart disease. Deaths from cancer (128) were significantly fewer than expected (168), mainly because of a deficit in the number of deaths from cancers related to smoking (cancers of the buccal cavity and pharynx, oesophagus, respiratory system, and bladder). There was also a lower than expected mortality from chronic bronchitis and emphysema. Data on saccharin consumption by BDA members showed that more than half of them used saccharin tablets daily, with an overall daily intake of three to six tablets, depending on age and sex. Information on a small sample of survivors from the mortality study suggested that about 23 % of them would have taken saccharin daily for 10 years or more and 10% for 25 years or more by the end of the follow-up. It was concluded that these relatively high levels of saccharin intake had not increased the risk of cancer in general among BDA members.
The subject of cancer mortality in diabetics has excited interest for some time and has been reviewed in detail by Kessler (1971) . Recently, bladder cancer mortality has been studied in diabetics as an indirect means of determining whether the use of saccharin increases the risk of this cancer in man (Armstrong and Doll, 1975) , but no such increase was shown. However, that study compared patients who died from cancer of the bladder with patients who died from other cancers (excluding cancers of the lung and pancreas), and thus it could not test whether We have therefore studied saccharin consumption by members of the British Diabetic Association (99% of whom suffer from diabetes) in parallel with their mortality to obtain further information on the relationship between saccharin consumption, diabetes, and cancer.
CANCER MORTALITY METHODS
A prospective study of mortality in diabetics was begun by one of us (AJL) (OPCS, 1974) , and was used to estimate the expected deaths in the manner described in the Appendix.
RESULTS
Overall, 1207 deaths occurred in the BDA members compared with 778 expected. Observed and expected numbers of deaths within major categories of underlying cause are shown in Table II . The excesses of deaths from diabetes mellitus and ischaemic heart disease account for almost all the overall excess. There was a deficit of deaths from malignant neoplasms (128 observed; 168 expected, P < 0'01).
Age-specific death rates for all types of cancer in male BDA members were used as reference rates to calculate age-standardized death rates from cancer in each sex, for deaths occurring from one to six years after entry to the study (Table III) Table IV . Also shown are the ratios of observed to expected numbers (standardized mortality ratios, SMRs) where either number was equal to or greater than 4 0. There was a significant deficit in the number of deaths from the smoking-related cancers in both sexes (cancers of the buccal cavity and pharynx, oesophagus, respiratory system, and bladder (Doll, 1972) 
SACCHARIN CONSUMPTION METHODS
In 1973 a questionnaire on artificial sweetener consumption was sent to a random sample of 4000 members of the BDA (approximately 10% of the total membership). Replies were received from 3096 members (77-4%), of whom 1600 were males, 1485 were females, and 11 did not indicate their sex. The males were aged between three and 93 years (average 50 -7), and the females between two and 93 years (average 52-6).
In 1975, a similar questionnaire, which included a question on the date of diagnosis of diabetes, was sent to a random sample of 100 members of the BDA who were included in the mortality study but who were known not to have died. The addresses of these people were about 10 years old and the response rate was expected to be fairly low; in fact replies were received from only 62 of these 100 diabetics. The remainder either could not be traced through the post office (11), had died recently (two), or did not respond to two letters (25). One of the responders indicated that she did not have diabetes. However, the low response rate is unlikely to be the result of the death of any of these 100 diabetics as their records at the NHSCR indicated that they were alive and only very rarely will the NHSCR not be notified of a death and the record be marked accordingly. Of the 61 diabetics who replied, 28 (45-9%) were men aged between 19 and 94 years (average 48-7) and 33 (54-1 %) were women aged between 13 and 82 years (average 57 -8).
RESULTS

SAMPLE OF ALL BDA MEMBERS
The daily use of saccharin tablets by the sample of all BDA members is shown in Table VI . A substantially higher proportion of men than women used saccharin tablets daily (age-standardized X1 = 48 -9, P < 0-001; Mantel and Haenszel, 1959) . There was significant heterogeneity by age in the proportions of men and women using saccharin tablets daily (men, X3 = 47-1, P < 0-001; women, X3 36-5, P < 0-001) and the trend towards a higher proportion of users with increasing age in men was significant but non-linear (X2 for trend = 22-7, P < 0-001; X2 for departures from linear trend 24-4, P < 0-001). The overall averages of 5-9 saccharin tablets daily for men and 3-4 daily for women are equivalent to 0-99 mg/kg per day and 0 -65 mg/kg per day respectively, assuming the same (Armstrong and Doll, 1974) ) rather than to a tendency to discontinue taking saccharin with a long duration of disease. Table VIII shows the frequency of use of saccharin tablets distributed by duration of diabetes at entry in the sample of survivors in the mortality study. This suggests that about 23 % (95 % confidence limits 13 to 36%) of all diabetics had used saccharin tablets daily for five years or more before entry to the study, and about 10% (95% confidence limits 4 to 21 %) for 20 years or more. Since the average period of follow-up in the mortality study was five years, by the end of follow-up about 23 % of diabetics would have used saccharin tablets daily for 10 years or more. (Armstrong and Doll, 1975) (OPCS, 1971 ) that only about 17 persons a year would have emigrated from a population of the size, age, and sex structure of the original sample of BDA members.
The suggestion that the deficit of smoking-related cancers in diabetics may be due to a relatively low consumption of cigarettes (Armstrong and Doll, 1975 ) is supported by evidence of a low mortality from other respiratory diseases related to smoking (chronic bronchitis and emphysema, Table V ). The degree of reduction in risk of lung cancer in diabetics observed in this study (about 50%) is, however, substantially greater than that which it was estimated could be explained by the difference between the proportions of smokers in diabetics and nondiabetics in Boston (12%; Armstrong and Doll, 1975) . This discrepancy is difficult to explain in the absence of adequate information on the smoking habits of diabetics in the United Kingdom and the effect of smoking on the cardiovascular mortality of diabetics. It is possible, however, that selective mortality of diabetic smokers from cardiovascular disease might not only reduce the proportion of current smokers among diabetics, but remove also those smokers at highest risk of another smokingrelated disease (by reason of amount smoked, method of smoking, etc.). Therefore, an estimate based only on the reduction in the proportion of current smokers might underestimate the total reduction which might be expected in the incidence of non-vascular diseases related to smoking.
In the analysis of this study, use was made of all conditions mentioned on the death certificate. This did not alter any positive conclusions which would have been made by studying the underlying causes only. It did, however, reveal that few death certificates for men mentioned emphysema, and showed a significant deficit in all mentions of rectal cancer. The second observation is based on small numbers (four observed, 10-4 expected) and, considering the many SMRs calculated, it could have occurred by chance. It is possible, however, in view of the recent suggestion that rectal cancer may be associated with a high intake of beer (Breslow and Enstrom, 1974) , that it may relate to the relatively low beer intake of diabetics (Armstrong, unpublished) . 
